Emugen Therapeutics
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
175 New Boston St Ste E, Woburn, Massach...Website
www.emugentx.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Emugen Therapeutics
Emugen Therapeutics is a biotechnology company specializing in next-generation gene therapies for central nervous system (CNS) disorders, utilizing advanced AAV capsids and precision delivery systems. Founded in 2021 by a team from the Broad Institute, Harvard, and MIT, the company aims to develop transformative treatments for severe genetic diseases. Their innovative approach focuses on diseases with well-defined genetic causes and aims to provide safe and effective therapies with minimal side effects. Emugen Therapeutics is based in the Boston metro area and is dedicated to redefining neurological care through their advanced research and discovery pipeline.Explore more
Emugen Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Emugen Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Emugen Therapeutics has new funding data
Earning: See what the market has to say on Emugen Therapeutics recently announced quarterly report
Click to see if Emugen Therapeutics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Emugen Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Emugen Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Emugen Therapeutics
Product Launch: Get notified when Emugen Therapeutics launches new products
Check if Emugen Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Emugen Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Emugen Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Emugen Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Emugen Therapeutics.
Emugen Therapeutics Tech Stack
A closer look at the technologies used by Emugen Therapeutics
Emugen Therapeutics News & Media
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Emugen Therapeutics
Sign Up For FreeTo access detailed company insights
Emugen Therapeutics is a biotechnology company specializing in next-generation gene therapies for central nervous system (CNS) disorders, utilizing advanced AAV capsids and precision delivery systems. Founded in 2021 by a team from the Broad Institute, Harvard, and MIT, the company aims to develop transformative treatments for severe genetic diseas... Read More
